Pilot Study of CYP2B6 Genetic Variation to Explore the Contribution of Nitrosamine Activation to Lung Carcinogenesis
We explored the contribution of nitrosamine metabolism to lung cancer in a pilot investigation of genetic variation in CYP2B6, a high-affinity enzymatic activator of tobacco-specific nitrosamines with a negligible role in nicotine metabolism. Previously we found that variation in CYP2A6 and CHRNA5-C...
Main Authors: | Rachel F. Tyndale, Margaret R. Spitz, Christopher I. Amos, Catherine A. Wassenaar, Qiong Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/14/4/8381 |
Similar Items
-
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
by: Juliana Rocha Santos, et al.
Published: (2015-02-01) -
Genetic Factors Associated with COPD Depend on the Ancestral Caucasian/Amerindian Component in the Mexican Population
by: Gloria Pérez-Rubio, et al.
Published: (2021-03-01) -
Surfactant inhibits ATP-induced release of interleukin-1β via nicotinic acetylcholine receptors[S]
by: Sören Backhaus, et al.
Published: (2017-06-01) -
Alpha-1 Antitrypsin Inhibits ATP-Mediated Release of Interleukin-1β via CD36 and Nicotinic Acetylcholine Receptors
by: Kathrin Siebers, et al.
Published: (2018-04-01) -
Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes
by: Veronika Grau, et al.
Published: (2019-01-01)